Business Wire

MA-IHRDC

29.7.2024 06:16:37 CEST | Business Wire | Press release

Share
Stepping Into the Future: IHRDC’s New Home in Historic Boston Bridges Tradition with Innovation

IHRDC, a worldwide leader in energy industry training, is excited to announce the relocation of its main office to a new location in the company’s long-time home base in the Back Bay neighborhood of Boston, Massachusetts. The move from Boylston Street to Park Plaza, just half a mile away, reflects the company’s dedication to better serving IHRDC’s learning and development clients and support its growing team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240728136557/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

New Headquarters for IHRDC: The global energy industry training leader is moving to the historic Saunders Building in Boston's Back Bay neighborhood. (Photo: Business Wire)

New address effective August 1, 2024:

20 Park Plaza, Suite 900, Boston, MA 02116 USA

Located in the historic Saunders Building, the new office provides a refreshed, modern office environment and historic charm. Highlights include an on-site training center, accommodations at the adjacent Hilton Park Plaza Hotel, and close proximity to the beautiful Boston Public Garden.

“This move is a strategic step to expand our operations and enhance our facilities to support our ongoing mission of developing people,” said IHRDC President & CEO Brad Donohue. “The new headquarters offers the flexible space and improved office layout we need to better accommodate our staff and meet the evolving needs of our business partners.”

IHRDC is committed to ensuring a smooth transition with minimal disruption to its services. Operations will continue as usual, with no anticipated downtime during the move.

Important Information:

  • New Address: 20 Park Plaza, Suite 900, Boston, MA 02116 USA
  • Phone Number: +1-617-536-0202 (remains unchanged)
  • Email: corporate@ihrdc.com (remains unchanged)

Clients, service-providers and friends are kindly requested to update their records using the new address. For your convenience, here is a map of the new location, including parking and public transportation options: https://www.google.com/maps/place/20+Park+Plaza,+Boston,+MA+02116/

“Thank you to our customers, partners, friends and families for their continued support and understanding as we make this exciting transition,” commented CEO Donohue. “We look forward to welcoming you all – future participants, alumni and existing clients – to our new headquarters and continuing to develop competence for the energy industry.”

About IHRDC:
International Human Resources Development Corporation (www.ihrdc.com) has been a global leader in training and competency development for the oil and gas industry for 55 years, offering the best Instructional Programs, e-Learning and Knowledge Solutions, and Competency Management products and services available to the industry today. The company is headquartered in Boston, USA with offices in London, Amsterdam, Abu Dhabi, Kuala Lumpur, and Lagos.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240728136557/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds1.9.2026 09:00:00 CEST | Press release

Global study finds price-sensitive shoppers will still pay more when products deliver clear, lasting benefits Global sales of consumer technology and durable goods are forecast to reach $1.4 trillion in 2026, up 5.1% year over year, even as 56% of consumers say they have delayed a technology purchase because of price or while waiting for a discount, according to new research from NIQ (NYSE: NIQ), the Official Global Insights Partner of IFA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901758503/en/ The era of automatic tech & durables upgrades is over. Released ahead of IFA 2026, which kicks off in Berlin on Sept. 4, 2026, NIQ today released its annual “State of Tech & Durables” report. Consumer Tech Trends 2027: How to Win When Every Purchase Must Be Justified examines how years of economic volatility have transformed technology purchasing behavior and what manufacturers and retailers must do to remain competitive. Key

Searchlight Capital Partners Announces Investment in Aderian Group1.9.2026 09:00:00 CEST | Press release

Partnership will support Aderian’s continued growth and expansion across the Nordic region Searchlight Capital Partners, L.P. ("Searchlight"), a leading global private investment firm, today announced an investment in Aderian Group ("Aderian" or the "Company"), a Nordic managed IT services provider serving more than 10,000 small and medium-sized enterprise ("SME") customers throughout Sweden and Norway. As part of the transaction, Aderian's management team will reinvest in the Company and remain meaningful shareholders alongside Searchlight, underscoring their continued commitment to Aderian's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901430715/en/ Aderian provides cloud, cybersecurity, AI and analytics, networking and modern workplace solutions. Since its founding in 2022, the Company has grown to approximately SEK 2.5 billion in revenue, with more than 850 employees and over 10,000 SME customers a

FluoSphera Licenses Debiopharm’s AbYlink™ Technology for 3D Antibody Characterization while Leveraging Leica Microsystems Viventis Deep Imaging Capabilities1.9.2026 09:00:00 CEST | Press release

New license agreement enables an integrated workflow combining antibody labeling, human-relevant 3D testing and quantitative imaging for antibody-based therapeutics Debiopharm (Debiopharm Research & Manufacturing), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases and FluoSphera, a Swiss biotechnology company developing advanced in vitro platforms to improve the prediction of drug efficacy and safety, today announced a new license agreement for use of AbYlink™, Debiopharm’s proprietary antibody conjugation technology. The agreement enables FluoSphera to offer biotechnology and pharmaceutical companies an integrated workflow combining regio-selective antibody labeling, high-throughput testing in human-relevant three-dimensional models and quantitative imaging analysis. The new offering is designed to support the characterization of antibody-drug conjugates (ADCs), bispecific antibodies, therape

Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer1.9.2026 08:30:00 CEST | Press release

Approval based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years Second approval for Enhertu in the EU in two months Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results fro

Paris Hilton Returns as the Face of KARL LAGERFELD as NOT-KARL Debuts for Fall–Winter 20261.9.2026 08:30:00 CEST | Press release

Following the success of the Maison's Fall-Winter 2025 and Spring-Summer 2026 campaigns, KARL LAGERFELD is delighted to announce the extension of its relationship with global entrepreneur, media personality and cultural icon Paris Hilton, continuing a partnership that has resonated with audiences around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831566835/en/ KARL LAGERFELD - Paris Hilton ©Matt Easton As the face of the Maison through Fall-Winter 2026 and Spring-Summer 2027, Paris Hilton returns for the next chapter of KARL LAGERFELD's From Paris With Love story, continuing to bring her signature confidence, wit and individuality. Photographed for the first time by Matt Easton, the Fall-Winter 2026 campaign introduces a new dimension to the narrative while remaining true to the House's established codes. At the heart of the Fall-Winter 2026 story, two masters of self-reinvention meet. Making his debut is NO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye